Skip to main content
. Author manuscript; available in PMC: 2021 Jul 15.
Published in final edited form as: Bioorg Med Chem. 2020 May 7;28(14):115546. doi: 10.1016/j.bmc.2020.115546

Figure 2.

Figure 2.

A) Full heatmap of antagonist activity for all 168 GPCRs against Y and ring distortion analogues. B) Focused heatmap of disease-relevant GPCRs that were antagonized during these investigations. C) Chemical structures and IC50 values for yohimbine analogues with diverse “gain-of-function” activity profiles against GPCR targets. (Note: color should be used)